Fifth Third Wealth Advisors
CYTK icon

Fifth Third Wealth Advisors’s Cytokinetics CYTK Stock Holding History

Fifth Third Wealth Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$441K Buy
6,685
+1,531
+30% +$117K 0.01% 580
2026
Q2 		$439K Buy
5,154
+1,830
+55% +$131K 0.01% 546
2026
Q1 		$219K Buy
3,324
+115
+4% +$7.31K 0.01% 756
2025
Q4 		$204K Buy
+3,209
New +$200K 0.01% 757

Other funds holding CYTK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.6B AUM 38.62% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return

Fifth Third Wealth Advisors's CYTK Position: Q3 2026 in Review

Fifth Third Wealth Advisors increased its Cytokinetics (CYTK) stake by 30% in Q3 2026, buying an estimated $117K and bringing the position to 6,685 shares worth $441K. The position accounts for 0.01% of the portfolio, ranked #580.

Fifth Third Wealth Advisors first reported a position in CYTK in Q4 2025 and has held it in 4 quarters since. 199 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • Fifth Third Wealth Advisors held 6,685 shares of Cytokinetics worth $441K as of Q3 2026.
  • Fifth Third Wealth Advisors bought 1,531 Cytokinetics shares in Q3 2026, an estimated $117K.
  • Cytokinetics made up 0.01% of Fifth Third Wealth Advisors's portfolio in Q3 2026, its #580 holding.
  • Fifth Third Wealth Advisors first reported a position in Cytokinetics in Q4 2025 and has held it in 4 quarters since.
  • 199 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.